2.2 Procedure Code Book

Total Page:16

File Type:pdf, Size:1020Kb

2.2 Procedure Code Book Ana P I 2.2 PROCEDURE CODE BOOK 1 Injections, Infusions And Inhalation Sedation 1.1 Injections, Infusions, And Inhalation Sedation Treatment Inhalation Sedation Use of analgesic nitrous oxide for alcohol and other withdrawal states (0203) A Per additional quarter-hour or part thereof (Rule: not applicable to UPFS – not to be charged) (0204) A Intravenous Treatment (see Note: How To Charge For Intravenous Infusions) Intravenous infusions (cutdown or push-in) (patients under two years): Cutdown and/or insertion of cannula - chargeable A once per 24 hours (0205) Intravenous infusions (push-in) (patients over two years): Insertion of cannula - chargeable once per 24 hours (0206) A Intravenous infusions (cutdown) (patients over two years): Cutdown and insertion of cannula - chargeable once per 24 A Hours (0207) Venesection Therapeutic venesection (Not to be used when blood is drawn for the purpose of laboratory investigations) (0208) A Umbilical artery cannulation at birth (0209) A Exchange transfusion: First and subsequent (including after-care) (0211) B Intravenous Treatment With Cytostatic Agents Chemotherapy: Intramuscular or subcutaneous: per injection.(0213) A Chemotherapy: Intravenous bolus technique: per injection.(0214) A Chemotherapy: Intravenous infusion technique: per injection.(0215) A 2 Integumentary System 2.1 Allergy Patch Tests First patch (0217) A Additional patch (0219) A Skin Prick Tests Skin-prick testing: Insect vemon, latex and drugs (0218) A Immediate hypersensitivity testing (Type I reaction): per antigen: Inhalant and food allergens (0220) A Delayed hypersensitivity testing (Type IV reaction): per antigen (0221) A 2.2 Skin (general) Intralesional Injection Into Areas Of Pathology E.g. Keloids Single (0222) A Multiple (0223) A Epilation: per session (0225) A Special treatment of severe acne cases, including draining of cysts, expressing of comedones and/or steaming, abrasive A A cleaning of skin and UVR per session (0227) PUVA Treatment (0228) A PUVA: Follow-up or maintenance once a week. (0229) A UVR-Treatment (0230) A UVR-Follow-up - for use of ultraviolet lamp (applied personally by the dermatologist) No charge to be levied if a nurse or A physiotherapist applies the ultraviolet lamp (0231) Biopsy Without Suturing First lesion (0233) A A Subsequent lesions (0234) A A Maximum for multiple additional lesions.(0235) A A Deep skin biopsy by surgical incision and suturing.(0237) A A Treatment Of Benign Skin Lesion By Chemo-cryotherapy First Lesion.(0241) A A Subsequent lesions (0242) A A Maximum for multiple additional lesions.(0243) A A Repair of nail bed.(0244) A A Removal Of Benign Lesion By Curetting Under Local Or General Anaesthesia Followed By Ana P I First Lesion.(0245) A A Subsequent lesions, each(0246) A A Removal Of Malignant Lesions By Curetting Under Local Or General Anaesthesia Followed By First Lesion.(0251) A A Subsequent lesions, each.(0252) A A Drainage of subcutaneous abscess onychia, paronychia, pulp space or avulsion of nail.(0255) A A Drainage of major hand or foot infection: drainage of major abscess with necrosis of tissue, involving deep fascia or requiring A B debridement, complete excision of pilonidal cyst or sinus(0257) Removal of foreign body superficial to deep deep fascia (except hands).(0259) A B Removal of foreign body deep to deep fascia (except hands).(0261) A A Kurtin Planing For Acne Scarring Whole face .(0271) B C Extensive.(0273) B B Limited .(0275) B A Subsequent planing of whole face within 12 months(0277) B B Surgical treatment for axillary hyperhidrosis.(0279) B B Laser Treatment For Small Skin Lesions First lesion.(0280) A B Subsequent lesions (0281) A B Maximum for multiple additional lesions.(0282) A B Laser Treatment For Large Skin Lesions Limited area.(0283) A B Extensive area.(0284) A B Whole face or other areas of equivalent size or larger (0285) A C 2.3 Major Plastic Repair (Rule: Only to be charged for medical indicated Procedures; otherwise cosmetic tariff grouping applies) Large skin grafts, composite skin grafts, large full thickness free skin grafts.(0289) B C Reconstructive procedures (including all stages) and skingraft by myocutaneous or fasciocutaneous flap (0290) B D Reconstructive procedures (including all stages) grafting by microvascular reanastomosis.(0291) C D Distant flaps: First stage.(0292) B C Contour grafts (0293) B C Vascularised bone graft with or without soft tissue with one or more sets microvascular anastomoses (0294) C D Local skin flaps (large, complicated).(0295) B C Other procedures of major technical nature.(0296) B C Subsequent major procedures for repair of same lesion.(0297) B B Lower abdominal dermo lipectomy.(0298) C C Major abdominal lipectomy with repositioning of umbilicus.(0299) C D 2.4 Lacerations, Scars, Tumours, Cysts And Other Skin Lesions Stitching Of Soft-tissue Injuries Stitching of wound (with or without local anaesthesia): Including normal after-care (0300) A B Multiple stitching of wound stitched at same session (0301) A A Deep laceration involving limited muscle damage (0302) B B Deep laceration involving extensive muscle damage (0303) B B Major debridement of wound, sloughectomy or secondary suture (0304) B A Needle biopsy - soft tissue (0305) A B Excision and repair by direct suture; excision nail fold or other minor procedures of similar magnitude (0307) A A Each additional small procedure done at the same time (0308) A A Radical excision of nailbed (0310) A A Excision of large benign tumour (more than 5 cm) (0311) A A Extensive resection for malignant soft tissue tumour including muscle (0313) B B Requiring repair by large skin graft or large local flap or other procedures of similar magnitude (0314) B B Requiring repair by small skin graft or small local flap or other procedures of similar magnitude (0315) B A 2.5 Breasts (Rule: Only to be charged for medical indicated Procedures; otherwise cosmetic tariff grouping applies) Fine needle aspiration for soft tissue (all body areas) (0316) B Aspiration of cyst or tumour.(0317) A A Mastotomy with exploration, drainage of abscess or removal of mammary implant.(0319) A A Biopsy or excision of cyst, benign tumour, aberrant breast tissue, duct papilloma.(0321) A B Subareola cone excision of ducts or wedge excision of breast (0323) A B Wedge excision of breast and axillary dissection.(0324) C C Total mastectomy.(0325) C C Total mastectomy with axillary gland biopsy.(0327) C C Total mastectomy with axillary gland dissection.(0329) C D Nipple and areola reconstruction (0330) B B Ana P I Subcutaneous Mastectomy For Disease Of Breast; Including Reconstruction But Excluding Cost Unilateral.(0331) B C Bilateral.(0333) B D Removal of breast implant by means of capsulectomy: Per breast (0334) B C Implantation of internal subpectoral mammary prosthesis in post mastectomy patients.(0335) B C Reduction: Mammoplasty For Pathological Hypertrophy Unilateral.(0337) C C Bilateral.(0339) C D Gynaecomastia Unilateral.(0341) A B Bilateral.(0343) B C 2.6 Burns Major Burns: Resuscitation (including supervision and intravenous therapy - first 48 hours) (0351) B D Tangential excision and grafting: Small (0353) B B Tangential excision and grafting: Large (0354) C C 2.7 Hands (skin) Skin flap in acute hand injuries where a flap is taken from a site remote from the injured finger or in cases of advancement C B flap e.g. Cutler(0355) Small skin graft in acute hand injury.(0357) C A Release of extensive skin contracture and or excision of scar tissue with major skin graft resurfacing (0359) C C Z-plasty (0361) B B Local flap and skin graft.(0363) B C Cross finger flap (all stages) (0365) B C Palmar flap (all stages) (0367) B C Distant flap: First stage (0369) B C Distant flap: Subsequent stage (0371) A B Transfer neurovascular island flap (0373) B C Syndactyly: Separation of, including skin graft for one web (0374) B C Dupuytren's Contracture Fasciotomy (0375) A A Fasciectomy (0376) A C 2.8 Acupuncture (Rule: charge Allied Health Professional Fee where applicable) Standard acupuncture (0377) A Laser acupuncture using more than 6 points (0378) A Electro-acupuncture (0379) A Scalp acupuncture (0380) A Micro-acupuncture (ear, hand) (0381) A 3 Musculo-skeletal System 3.1 Bones 3.1.1 Fractures (reduction – open/closed Under General Anaesthetic) Scapula (0383) A Clavicle (0387) A Percutaneous pinning of supracondylar fracture: Elbow - stand alone procedure (0388) B C Humerus (0389) A B Radius and/or Ulna (0391) A B Open reduction of both radius and ulna (0392) A C Carpal bone (0402) A B Bennett's fracture-dislocation (0403) A A Metacarpal: Simple (0405) A A Finger Phalanx: Distal Simple (0409) A Compound (0411) A A Proximal Or Middle Simple (0413) A A Compound (0415) A B Pelvis Closed (0417) B Operative reduction and fixation.(0419) B D Femur: Neck or Shaft.(0421) A C Ana P I Patella (0425) A A Tibia with or without fibula.(0429) A B Fibula shaft (0433) A Malleolus of ankle.(0435) A A Fracture-dislocation of ankle.(0437) A B Open reduction Talus fracture (0438) A B Tarsal bones and Os calcis.(0439) A A Calcanius reduction (0440) A B Toe Phalanx Distal: Simple.(0443) A Compound (0445) A A Other Simple (0447) A A Compound (0449) A A Sternum And/or Ribs Closed (0451) C Open reduction and fixation of multiple fractured ribs for flail chest (0452) C C Spine: With Or Without Paralysis Cervical (0455) C Rest (0456) C Compression Fracture Cervical (0461) C Rest (0462) C Spinous Or Transverse Processes Cervical (0463) C Rest (0464) C 3.1.1.1 Operations For Fractures Fractures involving large joints
Recommended publications
  • Summary Benchmarks for Preferred Practice Pattern® Guidelines
    SUMMARY BENCHMARKS FOR PREFERRED PRACTICE PATTERN® GUIDELINES TABLE OF CONTENTS Summary Benchmarks for Preferred Practice Pattern Guidelines Introduction . 1 Glaucoma Primary Open-Angle Glaucoma (Initial Evaluation) . 3 Primary Open-Angle Glaucoma (Follow-up Evaluation) . 5 Primary Open-Angle Glaucoma Suspect (Initial and Follow-up Evaluation) . 6 Primary Angle-Closure Disease (Initial Evaluation and Therapy) . 8 Retina Age-Related Macular Degeneration (Initial and Follow-up Evaluation) . 10 Age-Related Macular Degeneration (Management Recommendations) . 11 Diabetic Retinopathy (Initial and Follow-up Evaluation) . 12 Diabetic Retinopathy (Management Recommendations) . 13 Idiopathic Epiretinal Membrane and Vitreomacular Traction (Initial Evaluation and Therapy) . 14 Idiopathic Macular Hole (Initial Evaluation and Therapy) . 15 Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration (Initial and Follow-up Evaluation) . 17 Retinal and Ophthalmic Artery Occlusions (Initial Evaluation and Therapy) . 18 Retinal Vein Occlusions (Initial Evaluation and Therapy) . 19 Cataract/Anterior Segment Cataract (Initial and Follow-up Evaluation) . 20 Cornea/External Disease Bacterial Keratitis (Initial Evaluation) . 22 Bacterial Keratitis (Management Recommendations) . 23 Blepharitis (Initial and Follow-up Evaluation) . 24 Conjunctivitis (Initial Evaluation) . 25 Conjunctivitis (Management Recommendations) . 26 Corneal Ectasia (Initial Evaluation and Follow-up) . 27 Corneal Edema and Opacification (Initial Evaluation) . 28 Corneal Edema
    [Show full text]
  • Decompressive Craniectomy Following Severe Traumatic Brain Injury with an Initial Glasgow Coma Scale Score of 3 Or 4
    Case Report Clinics in Surgery Published: 03 Jul, 2019 Decompressive Craniectomy Following Severe Traumatic Brain Injury with an Initial Glasgow Coma Scale Score of 3 or 4 Afif AFIF* Department of Neurosurgery and Anatomy, Pierre Wertheimer Hospital, France Abstract Background: Decompressive craniectomy is a surgical management option for severe Traumatic Brain Injury (TBI). However, few studies have followed patients with TBI who have a Glasgow Coma Scale (GCS) score of 3 or 4 (out of 15). Decompressive craniectomy has been avoided in such patients owing to poor outcomes and poor functional recoveries in previous cases of treatment using this method. Clinical Presentation: Two patients are presented in our case series. The first suffered severe TBI following an aggression, with a GCS score of 3 and bilaterally dilated unreactive pupils. Brains CT scan showed right frontal fracture, bifrontal hematoma contusion, a fronto-temporo-parietal acute Subdural Hematoma (SDH) with a thickness of 14 mm on the right side, traumatic subarachnoid hemorrhage, with 20 mm of midline shift to the left side, and diffuses brain edema. The second presented with severe TBI following an automobile accident, with a GCS score of 4 and iso- reactive pupils. A brain CT scan showed bilateral fronto-temporal fracture, diffuse brain hematoma contusion, traumatic subarachnoid hemorrhage, right Extradural Hematoma (EDH) and bilateral fronto-temporo-parietal acute SDH that was more pronounced on the right side. Conclusion: Follow-up after the operations showed an Extended Glasgow Outcome Scale (EGOS) score of 8 and a very good functional recovery for both patients. Our case series suggests that in patients with severe TBI and a GCS score of 3 or 4; decompressive craniectomy can be performed OPEN ACCESS with good long-term neurological outcomes.
    [Show full text]
  • Cranioplasty: Indications, Procedures, and Outcome – an Institutional Experience Syed M
    OPEN ACCESS Editor: James I. Ausman, MD, PhD For entire Editorial Board visit : University of California, Los http://www.surgicalneurologyint.com Angeles, CA, USA SNI: General Neurosurgery Original Article Cranioplasty: Indications, procedures, and outcome – An institutional experience Syed M. Andrabi, Arif H. Sarmast, Altaf R. Kirmani, Abdul R. Bhat Department of Neurosurgery, Sher I Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India E‑mail: Syed M. Andrabi ‑ [email protected]; *Arif H. Sarmast ‑ [email protected]; Altaf R. Kirmani ‑ [email protected]; Abdul R. Bhat ‑ [email protected] *Corresponding author Received: 27 January 17 Accepted: 16 March 17 Published: 26 May 17 Abstract Background: Cranioplasty, the repair of a skull vault defect by insertion of an object (bone or nonbiological materials such as metal or plastic plates), is a well‑known procedure in modern neurosurgery. Brain protection and cosmetic aspects are the major indications of cranioplasty. A retroprospective study was conducted for evaluating the indications, materials used, complications, and outcome of cranioplasty. Methods: This study was prospective from August 2013 to September 2015 and retrospective from August 2010 to July 2013. In the retrospective study, patients files were retrieved from the mentioned date (August 2010 to July 2013) from the medical records and the findings were recorded. Abstracted data included age at the time of cranioplasty (years), sex (male or female), medical comorbidities (hypertension,
    [Show full text]
  • Case Series Sinking Skin Flap Syndrome Following Posttraumatic Hydrocephalus
    Hindawi Case Reports in Neurological Medicine Volume 2021, Article ID 6682310, 8 pages https://doi.org/10.1155/2021/6682310 Case Series Sinking Skin Flap Syndrome following Posttraumatic Hydrocephalus Ashish Chugh, Prashant Punia , and Sarang Gotecha Dr. D. Y. Patil Medical College and Hospital, Pimpri, Pune, Maharashtra, India Correspondence should be addressed to Prashant Punia; [email protected] Received 21 November 2020; Revised 8 January 2021; Accepted 11 January 2021; Published 9 February 2021 Academic Editor: Tapas Kumar Banerjee Copyright © 2021 Ashish Chugh et al. (is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction. Complications following craniotomy are not uncommon and Sinking Skin Flap Syndrome (SSFS) constitutes a rare entity that may present after a large Decompressive Craniectomy. Although the entity is widely reported, the literature mostly consists of case reports. Authors present a case series of three patients with review of literature highlighting the various factors which can prove therapeutic and can help in avoidance of complications. Materials and Methods. (e study was conducted over a period of 3 years, from 2016 to 2019, and included 212 patients who underwent unilateral Decompressive Craniectomy (DC) for trauma in our institute. All 212 patients underwent a similar DC following a strict institutional protocol and the craniectomies were performed by the same surgical team. At total of 160 patients survived and elective cranioplasty was planned at a 3-month interval. Out of a total of 160 patients who survived, 38 developed hydrocephalus, 3 patients presented with hydrocephalus acutely and had to be shunted before cranioplasty and underwent ventriculoperitoneal (VP) shunting on the opposite side of craniectomy.
    [Show full text]
  • Lower Gastrointestinal Bleeding
    Journal of Experimental and Clinical Medicine https://dergipark.org.tr/omuJecm Re view Article J Exp Clin Med 2021; 38(S1): 23-32 doi: 10.52142/omujecm.38.si.gastro.3 Lower gastrointestinal bleeding Serkan ÖCAL1,* , Mehmet Mutlu ÇATLI2 1 Department of Gastroenterology, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey 2Departmant of Internal Medicine, Antalya Training and Research Hospital, Antalya, Turkey Received: 13.12.2020 • Accepted/Published Online: 09.01.2021 • Final Version: 18.03.2021 Abstract Bleeding from the lower part of the digestive system that appears as hematocheZia (fresh blood, clot or cherry-colored stool) or melena (dark- colored tarry stool) is called lower gastrointestinal tract bleeding (lower GI bleeding) (or colonic bleeding). In the traditional definition, lower GI bleeding was generally classified as bleeding distal to the TreitZ ligament (duodenojejunal junction) as the border. In the last decade, GI bleeding has adopted three categories in some recent publications: Upper, middle, and lower. According to this category, bleeding from a source between the TreitZ ligament and the ileocecal valve is classified as middle GI bleeding, bleeding from the distal of the ileocecal valve is classified lower GI bleeding. Lower GI bleeding and hospitalization rates increase with aging. Currently, physicians managing lower GI bleeding have many different diagnostic and therapeutic options ranging from colonoscopy and flexible sigmoidoscopy to radiographic interventions such as scintigraphy or angiography. Lower GI bleeding often stops spontaneously and less common than upper GI bleeding. Even though no modality has emerged as the gold standard in the treatment of lower GI bleeding, colonoscopy has several advantages and is generally considered as the preferred initial test in most of the cases.
    [Show full text]
  • Obliterative Lefort Colpocleisis in a Large Group of Elderly Women
    Obliterative LeFort Colpocleisis in a Large Group of Elderly Women Salomon Zebede, MD, Aimee L. Smith, MD, Leon N. Plowright, MD, Aparna Hegde, MD, Vivian C. Aguilar, MD, and G. Willy Davila, MD OBJECTIVE: To report on anatomical and functional satisfaction. Associated morbidity and mortality related outcomes, patient satisfaction, and associated morbidity to the procedure are low. Colpocleisis remains an and mortality in patients undergoing LeFort colpocleisis. excellent surgical option for the elderly patient with METHODS: This was a retrospective case series of advanced pelvic organ prolapse. LeFort colpocleisis performed from January 2000 to (Obstet Gynecol 2013;121:279–84) October 2011. Data obtained from a urogynecologic DOI: http://10.1097/AOG.0b013e31827d8fdb database included demographics, comorbidities, medi- LEVEL OF EVIDENCE: III cations, and urinary and bowel symptoms. Prolapse was quantified using the pelvic organ prolapse quantification y 2050, the elderly will represent the largest section (POP-Q) examination. Operative characteristics were Bof the population and pelvic floor dysfunction is recorded. All patients underwent pelvic examination projected to affect 58.2 million women in the United and POP-Q assessment at follow-up visits. Patients also States. We thus can expect to see a increase in the were asked about urinary and bowel symptoms as well as demand for urogynecologic services in this popula- overall satisfaction. All intraoperative and postoperative tion.1,2 Most women older than age 65 years are surgical complications were recorded. afflicted with at least one chronic medical condition, RESULTS: Three hundred twenty-five patients under- and, with the rate of comorbid conditions increasing went LeFort colpocleisis.
    [Show full text]
  • Description of Alternative Approaches to Measure and Place a Value on Hospital Products in Seven Oecd Countries
    OECD Health Working Papers No. 56 Description of Alternative Approaches to Measure Luca Lorenzoni, and Place a Value Mark Pearson on Hospital Products in Seven OECD Countries https://dx.doi.org/10.1787/5kgdt91bpq24-en Unclassified DELSA/HEA/WD/HWP(2011)2 Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development 14-Apr-2011 ___________________________________________________________________________________________ _____________ English text only DIRECTORATE FOR EMPLOYMENT, LABOUR AND SOCIAL AFFAIRS HEALTH COMMITTEE Unclassified DELSA/HEA/WD/HWP(2011)2 Health Working Papers OECD HEALTH WORKING PAPERS NO. 56 DESCRIPTION OF ALTERNATIVE APPROACHES TO MEASURE AND PLACE A VALUE ON HOSPITAL PRODUCTS IN SEVEN OECD COUNTRIES Luca Lorenzoni and Mark Pearson JEL Classification: H51, I12, and I19 English text only JT03300281 Document complet disponible sur OLIS dans son format d'origine Complete document available on OLIS in its original format DELSA/HEA/WD/HWP(2011)2 DIRECTORATE FOR EMPLOYMENT, LABOUR AND SOCIAL AFFAIRS www.oecd.org/els OECD HEALTH WORKING PAPERS http://www.oecd.org/els/health/workingpapers This series is designed to make available to a wider readership health studies prepared for use within the OECD. Authorship is usually collective, but principal writers are named. The papers are generally available only in their original language – English or French – with a summary in the other. Comment on the series is welcome, and should be sent to the Directorate for Employment, Labour and Social Affairs, 2, rue André-Pascal, 75775 PARIS CEDEX 16, France. The opinions expressed and arguments employed here are the responsibility of the author(s) and do not necessarily reflect those of the OECD.
    [Show full text]
  • Outpatient Services
    Outpatient Services Coverage of Certain Services in the OUTPATIENT setting only* EFFECTIVE MARCH 9, 2015 bmchp.org | 888-566-0008 TO FIND A CODE OR WORD - While holding down the CTRL key, press the F key, type in Code, then press ENTER key Procedure Code Description 0213T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; single level 0214T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; second level (List separately in addition to code for primary procedure) 0215T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; third and any additional level(s) (List separately in addition to code for primary procedure) 0216T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, lumbar or sacral; single level 0217T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, lumbar or sacral; second level (List separately in addition to code for primary procedure) 0218T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound
    [Show full text]
  • Ureterolysis.Pdf
    Information about your procedure from The British Association of Urological Surgeons (BAUS) This leaflet contains evidence-based information about your proposed urological procedure. We have consulted specialist surgeons during its preparation, so that it represents best practice in UK urology. You should use it in addition to any advice already given to you. To view the online version of this leaflet, type the text below into your web browser: http://www.baus.org.uk/_userfiles/pages/files/Patients/Leaflets/Ureterolysis.pdf Key Points • Retroperitoneal fibrosis (RPF), also known as chronic periaortitis, forms at the back of your abdominal (tummy) cavity and can block your ureters (the tubes that carry urine from your kidneys to your bladder) • Ureterolysis is used to free your ureters from the blockage caused by the RPF • In most patients, the procedure involves open surgery through a long incision in your abdomen (tummy) but it can sometimes be done by laparoscopic (keyhole) surgery • To prevent further obstruction, we wrap your ureters in omentum (the fatty envelope inside your abdomen) or in a synthetic material • The procedure is usually reserved for patients in whom medical treatment has been unsuccessful • Care of patients with RPF is multi-disciplinary with physicians, expert surgeons and other specialists collaborating in your care What does this procedure involve? Freeing your ureters from scar tissue at the back of your abdomen to relieve the blockage and restore urine drainage from your kidneys. To prevent recurrence, we wrap your ureters in omentum (a sheet of fatty tissue found in your abdomen); if your omentum has been removed or is too small to use, we may wrap the ureters in a synthetic material.
    [Show full text]
  • Improved Preservation of Human Corneal Basement Membrane
    BritishJournal ofOphthalmology 1994; 78: 863-870 863 Improved preservation ofhuman corneal basement membrane following freezing of donor tissue for Br J Ophthalmol: first published as 10.1136/bjo.78.11.863 on 1 November 1994. Downloaded from epikeratophakia Robert D Young, W John Armitage, Paul Bowerman, Stuart D Cook, David L Easty Abstract States, good results continue to be achieved by Current methods for the production of the small number ofBritish surgeons performing lenticules for epikeratophakia involve rapid the technique.4 However, no comprehensive freezing, cryolathing, and slow warming of the account of its long term outcome has yet been donor cornea. We have found that this pro- published. cedure causes structural damage to the Several complications resulting in the failure epithelial basement membrane in the donor of epikeratophakia have been reported, includ- cornea which may subsequently contribute to ing infection, graft dehiscence, persistent inter- poor postoperative re-epithelialisation of the face haze or opacity, ulceration, and imperfect implant, leading to graft failure. Endeavouring re-epithelialisation. Among these, the failure of to overcome these problems, the effects of host epithelial cells to migrate over and re- cryoprotection of donor cornea were investi- surface the anterior face of the grafted tissue gated, using dimethyl sulphoxide, in conjunc- continues to be the major reason for the removal tion with different cooling and warming rates ofepikeratophakia lenticules.'-'0 as part of the protocol for cryolathing. The Epithelial healing is itselfa complex phenome- structural integrity of the epithelial basement non involving mitosis of host cells at the graft membrane zone (BMZ) was then assessed by periphery, centripetal migration, and attach- electron microscopy and by immunofluores- ment.
    [Show full text]
  • Curriculum Vitae
    CURRICULUM VITAE G. WILLY DAVILA, M.D. GUILLERMO H. DAVILA, M.D., FACOG, FPMRS Medical Director, Women and Children’s Services Holy Cross Medical Group Center for Urogynecology and Pelvic Floor Medicine Dorothy Mangurian Comprehensive Women’s Center Holy Cross Health Fort Lauderdale, Florida, USA Academic positions: Affiliate Professor, Florida Atlantic University School of Medicine Clinical Associate Professor, University of South Florida, Dept. of Obstetrics and Gynecology Address: Holy Cross HealthPlex Dorothy Mangurian Comprehensive Women’s Center 1000 NE 56th Street Fort Lauderdale, Florida 33334 Phone (954) 229-8660 FAX (954) 229-8659 Email: [email protected] Education 1976-1979 University of Texas at El Paso, Texas B.S. Biology 1976-1977 University of Bolivia Medical School, La Paz, Bolivia no degree 1979-1983 University of Texas Medical School, Houston, Texas M.D. Residency 1983-1987 University of Colorado Health Sciences Center, Denver, Colorado Obstetrics and Gynecology Postgraduate Training 1989 Gynecological Urology Clinical Preceptorship: Long Beach Memorial Hospital, University of California, Irvine Donald Ostergard, M.D., Director Previous Positions: 1999-2017 Chairman, Department of Gynecology, Cleveland Clinic Florida 1999-2018 Head, Section of Urogynecology and Reconstructive Pelvic Surgery Cleveland Clinic Florida Director, The Pelvic Floor Center at Cleveland Clinic Florida A National Association for Continence (NAFC) Center of Excellence in Pelvic Floor Care Director, Clinical Fellowship program - Urogynecology and Reconstructive Pelvic Surgery (2000-2007) 2015-2016 Clinical Director, Global Patient Services (Weston) Cleveland Clinic Foundation, International Center 2013-2016 Center Director, Obstetrics and Gynecology and Women’s Health Institute (Weston) Cleveland Clinic Foundation 1992-1999 Director, Colorado Gynecology and Continence Center, P.C.
    [Show full text]
  • Colpocleisis (Closing the Vagina to Treat Prolapse)
    Colpocleisis (Closing the vagina to treat prolapse) Patient Information Leaflet About this leaflet The information provided in this leaflet should be used as a guide. There may be some variation in how each gynaecologist performs the procedure, the care procedures on the ward immediately after your operation and the advice given to you when you get home. You should ask your gynaecologist about any concerns that you may have. You should take your time to read this leaflet. A page is provided at the end of the leaflet for you to write down any questions you may have. It is your right to know about your planned operation/procedure, why it has been recommended, what the alternatives are and what the risks and benefits are. These should be covered in this leaflet. You may also wish to ask about your gynaecologist’s personal experience and results of treating your condition. Benefits and risks The success and the risks of most operations carried out to treat prolapse and incontinence have been poorly studied and so it is often not possible to define them clearly. In this leaflet risks may be referred to as common, rare etc. or an approximate level of risk may be given. Further information about risk is explained in a leaflet published by the Royal College of Obstetricians and Gynaecologists “Understanding how risk is discussed in healthcare”. https://www.rcog.org.uk/globalassets/documents/patients/patient-information-leaflets/pi- understanding-risk.pdf The following table is taken from that leaflet British Society of Urogynaecology (BSUG) database In order to better understand the success and risks of surgery for prolapse and incontinence the British Society of Urogynaecology has established a national database.
    [Show full text]